343 Shares in Axon Enterprise, Inc $AXON Purchased by Sivia Capital Partners LLC

Sivia Capital Partners LLC purchased a new position in shares of Axon Enterprise, Inc (NASDAQ:AXON) in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor purchased 343 shares of the biotechnology company’s stock, valued at approximately $284,000.

Several other large investors have also recently added to or reduced their stakes in the company. LaSalle St. Investment Advisors LLC raised its holdings in Axon Enterprise by 2.1% during the first quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company’s stock worth $408,000 after purchasing an additional 16 shares in the last quarter. Smartleaf Asset Management LLC raised its holdings in Axon Enterprise by 5.0% during the first quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company’s stock worth $203,000 after purchasing an additional 18 shares in the last quarter. Pinion Investment Advisors LLC grew its position in Axon Enterprise by 3.0% during the first quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company’s stock worth $341,000 after buying an additional 19 shares during the period. Kentucky Retirement Systems grew its position in Axon Enterprise by 0.4% during the first quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company’s stock worth $2,605,000 after buying an additional 19 shares during the period. Finally, WCM Investment Management LLC grew its position in Axon Enterprise by 0.8% during the first quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company’s stock worth $1,306,000 after buying an additional 19 shares during the period. 79.08% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In related news, President Joshua Isner sold 15,919 shares of the firm’s stock in a transaction that occurred on Friday, August 15th. The shares were sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the sale, the president owned 238,379 shares in the company, valued at approximately $177,892,712.54. This trade represents a 6.26% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Brittany Bagley sold 870 shares of the firm’s stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $773.25, for a total transaction of $672,727.50. Following the sale, the chief financial officer owned 113,022 shares in the company, valued at approximately $87,394,261.50. This trade represents a 0.76% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 44,932 shares of company stock valued at $34,408,816 in the last 90 days. Insiders own 4.40% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the topic of several recent analyst reports. Needham & Company LLC set a $870.00 target price on shares of Axon Enterprise and gave the stock a “buy” rating in a research report on Tuesday, August 5th. Morgan Stanley set a $885.00 target price on shares of Axon Enterprise and gave the stock an “overweight” rating in a research report on Friday, July 11th. Bank of America upped their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a research report on Wednesday, August 6th. Wolfe Research initiated coverage on shares of Axon Enterprise in a research report on Monday, July 7th. They set an “outperform” rating on the stock. Finally, Craig Hallum upgraded shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 target price on the stock in a research report on Tuesday, August 5th. Thirteen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $837.69.

Axon Enterprise Stock Up 1.9%

AXON stock opened at $766.47 on Friday. The company’s 50 day simple moving average is $759.07 and its 200-day simple moving average is $692.51. The firm has a market capitalization of $60.17 billion, a PE ratio of 189.25, a P/E/G ratio of 27.59 and a beta of 1.40. Axon Enterprise, Inc has a 12 month low of $383.03 and a 12 month high of $885.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The business had revenue of $668.54 million for the quarter, compared to analyst estimates of $641.77 million. During the same period in the prior year, the business earned $1.20 earnings per share. The company’s quarterly revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. Equities analysts expect that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Company Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.